Resolution of nicotinic acid-induced acanthosis nigricans by substitution of an analogue (acipimox) in a patient with type V hyperlipidaemia.
Coates
P
P
Department of Medicine, University Hospital of Wales, Cardiff, U.K.
Shuttleworth
D
D
Rees
A
A
D000052:Acanthosis Nigricans / Q000139:chemically induced* / Q000473:pathology; D000328:Adult; D001365:Axilla; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D011719:Pyrazines; C027696:acipimox